Skip to main content
Clobetasol Propionate
prod 8

Clobetasol Propionate

Status

Commercial

Therapeutic Category

Anti-inflammatory

Pharmacopoeia

IP/ BP / USP/ EP

Cas no.

21522 –46– 7

DMF Status

CEP No. R1-CEP 2009 – 315-Rev 02

Product Remarks

ANVISA, KFDA, CDE-NMPA

Application - cream, foam, gel, lotion, ointment, shampoo, solution, emollient

Drug Description

Clobetasol propionate is indicated to treat moderate to severe plaque psoriasis. Clobetasol propionate is a prednisolone derivative with higher specificity for glucocorticoid receptors than mineralocorticoid receptors. Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces. Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.

Contact Us

Connect with Avik Today